Share this story
Elon Musk sits as President-elect Donald Trump meets with House Republicans in Washington, D.C., November 13, 2024.
Brian Snyder/Reuters
We have a drug to reduce obesity and associated illness, and the leader of MAHA just isn’t into it.
The New York Times ran an article the other day on the clash between Robert Kennedy Jr. and Elon Musk over Ozempic and similar so-called GLP-1 drugs that help people lose weight; seeing dark forces at work, RFK Jr. is highly suspicious, and seeing revolutionary technological progress, Elon Musk is in favor.
About the Author
Rich Lowry is the editor in chief of National Review.
Advertisement
Advertisement
We have a drug to reduce obesity and associated illness, and the leader of MAHA just isn’t into it.
The New York Times ran an article the other day on the clash between Robert Kennedy Jr. and Elon Musk over Ozempic and similar so-called GLP-1 drugs that help people lose weight; seeing dark forces at work, RFK Jr. is highly suspicious, and seeing revolutionary technological progress, Elon Musk is in favor.
By continuing, you agree to our terms of service and privacy policy.
About the Author
Rich Lowry is the editor in chief of National Review.
Advertisement
Advertisement
Comments